
WALD Stock Forecast & Price Target
WALD Analyst Ratings
Bulls say
Waldencast is expected to experience a positive trajectory in the coming years due to its successful Obagi Skincare segment, which has seen consistent year-over-year growth. While its Milk Makeup segment has experienced some challenges, the company is actively investing in key launches to drive growth. In FY25, the company's sales met expectations and it is taking measures to improve its adjusted gross margin through inventory management. However, risks such as dependence on third-party suppliers, dilution from potential new securities and an ongoing SEC investigation could impact its future growth.
Bears say
Waldencast is facing several challenges, including soft consumption and lackluster performance in its Milk Makeup segment, leading to disappointing earnings results and a decrease in revenue expectations for FY25. Additionally, the ongoing SEC investigation and strategic review have created uncertainty and increased costs for the company. This, combined with the potential for increased competition in the beauty and wellness industry, contributes to a negative outlook for the stock.
This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.
WALD Analyst Forecast & Price Prediction
Start investing in WALD
Order type
Buy in
Order amount
Est. shares
0 shares